admin.eporgen.com

eporgen.com

About Eporgen Venture

http://www.eporgen.com/about.asp

Eporgen commenced operations in 2005 and is based in the Silvano Fumero Bioindustry Park. Close to Ivrea in the Piedmont region of Italy. With about 20 staff in total, Eporgen and its start-up companies operate an efficient business model that combines aspects of a venture capital and a virtual pharma company and relies on a network of scientific advisors, contract research organisations and academic institutions. VAT 08982780010 BioIndustry Park Silvano Fumero - Via Ribes 5, 10010 Colleretto Giacosa (TO).

eporgen.com

Eporgen - Nurturing the winners

http://www.eporgen.com/aziende/rotalactis.asp

Originated from the National Research Council and the University of Torino; established in 2008, it operates in the area of nutraceuticals. One patent filed in 2010. Identification and isolation of lactadherin with anti-rotavirus activity from the proteins associated with the fat globules in equine (donkey) milk. Complete amino-acid sequencing of the equine lactadherin protein has been accomplished. Peptides derived from equine lactadherin with anti-rotavirus activity have been identified and an in vitro.

eporgen.com

Where is Eporgen. Contact Us

http://www.eporgen.com/where.asp

Eporgen S.p.A. C/o Silvano Fumero Bioindustry Park. Via Ribes, 5. 10010 Colleretto Giacosa (TO). Tel 39 0125 561000. Fax 39 0125 538791. E mail: info@eporgen.com. Eporgen is searching for suitable partners for collaborations and out- licensing of projects within its portfolio of start-up companies. To discuss potential opportunities, please contact us at the following e mail address: info@eporgen.com. In una mappa di dimensioni maggiori. 390125.561000 - Fax.

eporgen.com

Eporgen - Nurturing the winners

http://www.eporgen.com/aziende/spiderbiotech.asp

Originated from the University of Siena; established in 2005, it operates in the field of anti-infectives. Two patents filed in 2008 and 2009. Selected publications for antibacterial program:. Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties , Bruschi et al. 2010) Peptides, 31. Link: http:/ www.ncbi.nlm.nih.gov/pubmed/20438783. 2007) Nanomedicine, 3. Selected publications for antiviral program:. Interest...

eporgen.com

Glyconova

http://www.eporgen.com/aziende/glyconova.asp

Established in 2009 by Dr. Ghiselli, a former Professor of Pathology and Cellular Biology at the Thomas Jefferson University of Philadelphia (U.S.A.); it operates in the fields of glycobiology and anti-cancer drug discovery. GLCE has been validated as a target for the development of anti-tumor agents. Completed a medicinal chemistry program where 1,500 molecules have been screened and 30 hits, belonging to different chemical families, identified to date. 390125.561000 - Fax.

eporgen.com

Genovax

http://www.eporgen.com/aziende/genovax.asp

Originated from the University of Genova; established in 2008, it operates in the area of therapeutic vaccines for chronic diseases. Genovax has developed novel vaccines for the treatment of cancer (renal and prostate) and Systemic Lupus Erythematosus (SLE). One patent filed in 2007. Selected publications for SLE:. Link: http:/ www.ncbi.nlm.nih.gov/pubmed/17530718. Spontaneous transgenesis of human B lymphocytes , Filaci et al. (2004) Gene Therapy, 11. 390125.561000 - Fax.

eporgen.com

Target Heart Biotech

http://www.eporgen.com/aziende/targetheart.asp

Originated from the University of Torino; established in 2005, it operates in the cardiovascular field. Two patents filed in 2002 and 2010. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload , De Acetis et al. (2005), Circulation Research, 96. Link: http:/ www.ncbi.nlm.nih.gov/pubmed/15860758. 2003) Nature Medicine, 9. Link: http:/ www.ncbi.nlm.nih.gov/pubmed/12496958. 2007) Eur. J. Heart Failure, 9. Pharmacokinetic tests (pre-clinical model in a...

eporgen.com

Narvalus

http://www.eporgen.com/aziende/narvalus.asp

Originated from the University of Padova;established in 2005, it operates in the area of nanotechnology and has developed a technology for the electroporation of individual cells. One patent filed in 2004. Selected publication: Space and time-resolved gene expression experiments on cultured mammalian cells by a single-cell electroporation microarray , Vassanelli et al. 2008) N Biotechnol., 25. Link: http:/ www.ncbi.nlm.nih.gov/pubmed/18504020. Set-up and validation of the second generation prototype, whi...

eporgen.com

NoToPharm

http://www.eporgen.com/aziende/notopharm.asp

Spin-off of the Universities of Piemonte Orientale and Torino; established in 2007, it operates in the field of diagnosis and treatment of autoimmune disorders. NoToPharm discovers molecular markers whose presence in the patient s blood is instrumental for the diagnosis and prognosis of autoimmune disorders associated with viral infections, with a specific application in Systemic Sclerosis. Two patents filed in 2008 and 2010. Link: http:/ www.ncbi.nlm.nih.gov/pubmed/21134960. 2010) Autoimmunity, 43.

eporgen.com

Eporgen product portfolio

http://www.eporgen.com/products.asp

VAT 08982780010 BioIndustry Park Silvano Fumero - Via Ribes 5, 10010 Colleretto Giacosa (TO). 390125.561000 - Fax.